Why is Aarti Drugs falling/rising?

As of 11-Aug, Aarti Drugs Ltd is experiencing a slight decline in its stock price, currently at 488.30, reflecting a change of -0.25, or -0.05%. The stock has underperformed its sector by -0.96% today and has been on a consecutive downward trend for the last two days, resulting in a total decline of -3.63% during this period. Over the past week, the stock has decreased by -0.94%, while it has shown a modest increase of +3.10% over the past month. Despite a year-to-date gain of +6.00%, the stock has underperformed over the last year with a return of -5.53%. The stock is currently trading above its 50-day, 100-day, and 200-day moving averages but below its 5-day and 20-day moving averages. Additionally, there has been a significant drop in investor participation, with delivery volume falling by -64.71% compared to the 5-day average.
In the broader market context, Aarti Drugs' recent performance contrasts with the Sensex, which has declined by -0.51% over the past week and -2.30% over the past month. The company benefits from high management efficiency, reflected in a return on capital employed (ROCE) of 17.84%, and a low debt-to-equity ratio of 0.45 times, indicating financial stability. Despite the stock's recent price decline, it is trading at a discount compared to its peers' average historical valuations, and its profits have increased by 20.4% over the past year, contributing to an attractive PEG ratio of 1.2. However, the recent drop in delivery volume and consecutive price falls suggest a cautious sentiment among investors, impacting the stock's short-term performance.